Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Gastroenterology | Infections and Infectious Diseases | Family Medicine
Disease Category: Clostridium Difficile-Associated Diarrhea
Location: United States, NY

Clinical Trial Details

Overview

Research Study Summary

C. diff

Purpose

Let’s Try to Break the Cycle

If a patient has C. diff now, they have up to a 60% chance of having C. diff again.*

The MODIFY Study in testing the safety, effectiveness and tolerability of an investigational drug to see if it can help prevent C. diff reoccurrences.

Participants will receive study-related exams and study drug at no charge. There are risks associated with participation in this clinical research study. They study doctor will explain the study requirements, possible benefits, and potential risks to you before you decide to participate.

Patient Inclusion Criteria:
Eligible participants must:

  • Be at least 18 years of age
  • Have a diagnosis of C. diff (including a positive stool test)

To Learn more
Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Lorraine Breuer, Vice President for Research
Parker Jewish Institute
271-11 76th Avenue
New Hyde Park, NY 11040
Phone: 718-289-2102
Fax: 718-289-2248

View Map

Research Center Information: Parker Jewish Institute

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 180813

Date Last Changed: July 19, 2013


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.